Introduction
Importance of microembolization and inflammation in atherosclerotic heart disease
GUSTO IV: Expanding therapeutic options in acute coronary syndromes
Glycoprotein IIb/IIIa inhibitors: Therapeutic applications in acute ST-segment elevation myocardial infarction
Facilitated percutaneous coronary intervention: A novel concept in expediting and improving acute myocardial infarction care
Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine
Critical concepts in cost-effectiveness for cardiovascular specialists
Abciximab: Cost-effective survival advantage in clinical trials and clinical practice
Exploring the issues of appropriate dosing in the treatment of acute myocardial infarction: Potential benefits of bolus fibrinolytic agents